...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Pharmacokinetics, Safety and Antiviral Activity of Tenofovir exalidex(TXL), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to HBV-Infected Subjects: A 28 Day Study Final Analyses
【24h】

Pharmacokinetics, Safety and Antiviral Activity of Tenofovir exalidex(TXL), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to HBV-Infected Subjects: A 28 Day Study Final Analyses

机译:Tenofovir Exalidex(TXL)的药代动力学,安全性和抗病毒活性,一种新型替诺福韦的前药,以升递多剂量给HBV感染的受试者施用:28天的研究最终分析

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号